These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

342 related items for PubMed ID: 21123390

  • 1. Impact of valency of a glycoprotein B-specific monoclonal antibody on neutralization of herpes simplex virus.
    Krawczyk A, Krauss J, Eis-Hübinger AM, Däumer MP, Schwarzenbacher R, Dittmer U, Schneweis KE, Jäger D, Roggendorf M, Arndt MA.
    J Virol; 2011 Feb; 85(4):1793-803. PubMed ID: 21123390
    [Abstract] [Full Text] [Related]

  • 2. Characterisation of the epitope for a herpes simplex virus glycoprotein B-specific monoclonal antibody with high protective capacity.
    Däumer MP, Schneider B, Giesen DM, Aziz S, Kaiser R, Kupfer B, Schneweis KE, Schneider-Mergener J, Reineke U, Matz B, Eis-Hübinger AM.
    Med Microbiol Immunol; 2011 May; 200(2):85-97. PubMed ID: 20931340
    [Abstract] [Full Text] [Related]

  • 3. Glycoprotein C of Herpes Simplex Virus 1 Shields Glycoprotein B from Antibody Neutralization.
    Komala Sari T, Gianopulos KA, Nicola AV.
    J Virol; 2020 Feb 14; 94(5):. PubMed ID: 31826995
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A novel glycoprotein D-specific monoclonal antibody neutralizes herpes simplex virus.
    Du R, Wang L, Xu H, Wang Z, Zhang T, Wang M, Ning Y, Deng F, Hu Z, Wang H, Li Y.
    Antiviral Res; 2017 Nov 14; 147():131-141. PubMed ID: 29061442
    [Abstract] [Full Text] [Related]

  • 6. Patient-Specific Neutralizing Antibody Responses to Herpes Simplex Virus Are Attributed to Epitopes on gD, gB, or Both and Can Be Type Specific.
    Cairns TM, Huang ZY, Gallagher JR, Lin Y, Lou H, Whitbeck JC, Wald A, Cohen GH, Eisenberg RJ.
    J Virol; 2015 Sep 14; 89(18):9213-31. PubMed ID: 26109729
    [Abstract] [Full Text] [Related]

  • 7. The Fusion Loops of the Initial Prefusion Conformation of Herpes Simplex Virus 1 Fusion Protein Point Toward the Membrane.
    Fontana J, Atanasiu D, Saw WT, Gallagher JR, Cox RG, Whitbeck JC, Brown LM, Eisenberg RJ, Cohen GH.
    mBio; 2017 Aug 22; 8(4):. PubMed ID: 28830949
    [Abstract] [Full Text] [Related]

  • 8. Structural basis for the antibody neutralization of herpes simplex virus.
    Lee CC, Lin LL, Chan WE, Ko TP, Lai JS, Wang AH.
    Acta Crystallogr D Biol Crystallogr; 2013 Oct 22; 69(Pt 10):1935-45. PubMed ID: 24100313
    [Abstract] [Full Text] [Related]

  • 9. Cell-to-Cell Spread Blocking Activity Is Extremely Limited in the Sera of Herpes Simplex Virus 1 (HSV-1)- and HSV-2-Infected Subjects.
    Criscuolo E, Castelli M, Diotti RA, Amato V, Burioni R, Clementi M, Ambrosi A, Mancini N, Clementi N.
    J Virol; 2019 Jun 01; 93(11):. PubMed ID: 30867302
    [Abstract] [Full Text] [Related]

  • 10. Development of a highly effective combination monoclonal antibody therapy against Herpes simplex virus.
    Seyfizadeh N, Kalbermatter D, Imhof T, Ries M, Müller C, Jenner L, Blumenschein E, Yendrzheyevskiy A, Grün F, Moog K, Eckert D, Engel R, Diebolder P, Chami M, Krauss J, Schaller T, Arndt M.
    J Biomed Sci; 2024 May 28; 31(1):56. PubMed ID: 38807208
    [Abstract] [Full Text] [Related]

  • 11. Vaccine-induced antibodies to herpes simplex virus glycoprotein D epitopes involved in virus entry and cell-to-cell spread correlate with protection against genital disease in guinea pigs.
    Hook LM, Cairns TM, Awasthi S, Brooks BD, Ditto NT, Eisenberg RJ, Cohen GH, Friedman HM.
    PLoS Pathog; 2018 May 28; 14(5):e1007095. PubMed ID: 29791513
    [Abstract] [Full Text] [Related]

  • 12. [Monoclonal antibodies in the diagnosis of infections caused by the herpes simplex virus].
    Klimova RR, Masalova OV, Atanadze SN, Kushch AA.
    Zh Mikrobiol Epidemiol Immunobiol; 1999 May 28; (5):99-103. PubMed ID: 10852033
    [Abstract] [Full Text] [Related]

  • 13. Better neutralization of herpes simplex virus type 1 (HSV-1) than HSV-2 by antibody from recipients of GlaxoSmithKline HSV-2 glycoprotein D2 subunit vaccine.
    Awasthi S, Belshe RB, Friedman HM.
    J Infect Dis; 2014 Aug 15; 210(4):571-5. PubMed ID: 24652496
    [Abstract] [Full Text] [Related]

  • 14. Epitope mapping of herpes simplex virus type 2 gH/gL defines distinct antigenic sites, including some associated with biological function.
    Cairns TM, Shaner MS, Zuo Y, Ponce-de-Leon M, Baribaud I, Eisenberg RJ, Cohen GH, Whitbeck JC.
    J Virol; 2006 Mar 15; 80(6):2596-608. PubMed ID: 16501070
    [Abstract] [Full Text] [Related]

  • 15. Herpes simplex virus type 1-specific immunity induced by peptides corresponding to an antigenic site of glycoprotein B.
    Mester JC, Highlander SL, Osmand AP, Glorioso JC, Rouse BT.
    J Virol; 1990 Nov 15; 64(11):5277-83. PubMed ID: 1698994
    [Abstract] [Full Text] [Related]

  • 16. Blocking herpes simplex virus 2 glycoprotein E immune evasion as an approach to enhance efficacy of a trivalent subunit antigen vaccine for genital herpes.
    Awasthi S, Huang J, Shaw C, Friedman HM.
    J Virol; 2014 Aug 15; 88(15):8421-32. PubMed ID: 24829358
    [Abstract] [Full Text] [Related]

  • 17. Monoclonal antibodies to the distinct antigenic sites on glycoproteins C and B and their protective abilities in herpes simplex virus infection.
    Bystrická M, Petríková M, Zatovicová M, Soláriková L, Kostolanský F, Mucha V, Russ G.
    Acta Virol; 1997 Feb 15; 41(1):5-12. PubMed ID: 9199708
    [Abstract] [Full Text] [Related]

  • 18. Antigenic and mutational analyses of herpes simplex virus glycoprotein B reveal four functional regions.
    Bender FC, Samanta M, Heldwein EE, de Leon MP, Bilman E, Lou H, Whitbeck JC, Eisenberg RJ, Cohen GH.
    J Virol; 2007 Apr 15; 81(8):3827-41. PubMed ID: 17267495
    [Abstract] [Full Text] [Related]

  • 19. Blocking antibody access to neutralizing domains on glycoproteins involved in entry as a novel mechanism of immune evasion by herpes simplex virus type 1 glycoproteins C and E.
    Hook LM, Huang J, Jiang M, Hodinka R, Friedman HM.
    J Virol; 2008 Jul 15; 82(14):6935-41. PubMed ID: 18480440
    [Abstract] [Full Text] [Related]

  • 20. Structure-function analysis of herpes simplex virus glycoprotein B with fusion-from-without activity.
    Roller DG, Dollery SJ, Doyle JL, Nicola AV.
    Virology; 2008 Dec 20; 382(2):207-16. PubMed ID: 18950828
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.